Deepak Chadha - Jun 14, 2021 Form 4 Insider Report for Brickell Biotech, Inc. (FRTX)

Role
Chief Research & Dev. Officer
Signature
/s/ Christine G. Long, Attorney-in-Fact for Deepak Chadha (power of attorney previously filed)
Stock symbol
FRTX
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
4
Date filed
6/14/2021, 04:45 PM
Previous filing
May 19, 2021
Next filing
May 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FRTX Stock Option (right to buy) Award $0 +250K $0.00 250K Jun 14, 2021 Common Stock 250K $0.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest 25% on June 14, 2022, and the remainder will vest in equal monthly installments over the following three years.